-
Je něco špatně v tomto záznamu ?
AML-associated mutation of nucleophosmin compromises its interaction with nucleolin
M. Šašinková, A. Holoubek, P. Otevřelová, K. Kuželová, B. Brodská,
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
NV16-30268A
MZ0
CEP - Centrální evidence projektů
- MeSH
- akutní myeloidní leukemie genetika metabolismus patologie MeSH
- buněčné jadérko genetika metabolismus patologie MeSH
- fosfoproteiny genetika metabolismus MeSH
- HEK293 buňky MeSH
- jaderné proteiny genetika metabolismus MeSH
- lidé MeSH
- multiproteinové komplexy genetika metabolismus MeSH
- mutace * MeSH
- nádorové buněčné linie MeSH
- nádorové proteiny genetika metabolismus MeSH
- proteiny vázající RNA genetika metabolismus MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
C-terminal mutations of the nucleolar protein nucleophosmin (NPM) are the most frequent genetic aberration detected in acute myeloid leukemia (AML) with normal karyotype. The mutations cause aberrant cytoplasmic localization of NPM and lead to loss of functions associated with NPM nucleolar localization, e.g. in ribosome biogenesis or DNA-damage repair. NPM has many interaction partners and some of them were proved to interact also with the mutated form (NPMmut) and due to this interaction thereby to be withdrawn from their site of action. We analyzed the impact of the mutation on NPM interaction with nucleolin (NCL) which is also prevalently localized into the nucleolus and cooperates with wild-type NPM (NPMwt) in many cellular processes. We revealed that the NCL-NPM complex formation is completely abolished by the mutation and that the presence/absence of the interaction is not affected by drugs causing genotoxic stress or differentiation. Deregulation resulting from changes of NCL/NPMwt ratio may contribute to leukemogenesis.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19028259
- 003
- CZ-PrNML
- 005
- 20190816131621.0
- 007
- ta
- 008
- 190813s2018 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.biocel.2018.08.008 $2 doi
- 035 __
- $a (PubMed)30130654
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Šašinková, Markéta $u Institute of Hematology and Blood Transfusion, U Nemocnice 1, 128 20 Prague 2, Czech Republic.
- 245 10
- $a AML-associated mutation of nucleophosmin compromises its interaction with nucleolin / $c M. Šašinková, A. Holoubek, P. Otevřelová, K. Kuželová, B. Brodská,
- 520 9_
- $a C-terminal mutations of the nucleolar protein nucleophosmin (NPM) are the most frequent genetic aberration detected in acute myeloid leukemia (AML) with normal karyotype. The mutations cause aberrant cytoplasmic localization of NPM and lead to loss of functions associated with NPM nucleolar localization, e.g. in ribosome biogenesis or DNA-damage repair. NPM has many interaction partners and some of them were proved to interact also with the mutated form (NPMmut) and due to this interaction thereby to be withdrawn from their site of action. We analyzed the impact of the mutation on NPM interaction with nucleolin (NCL) which is also prevalently localized into the nucleolus and cooperates with wild-type NPM (NPMwt) in many cellular processes. We revealed that the NCL-NPM complex formation is completely abolished by the mutation and that the presence/absence of the interaction is not affected by drugs causing genotoxic stress or differentiation. Deregulation resulting from changes of NCL/NPMwt ratio may contribute to leukemogenesis.
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a buněčné jadérko $x genetika $x metabolismus $x patologie $7 D002466
- 650 _2
- $a HEK293 buňky $7 D057809
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a akutní myeloidní leukemie $x genetika $x metabolismus $x patologie $7 D015470
- 650 _2
- $a multiproteinové komplexy $x genetika $x metabolismus $7 D046912
- 650 12
- $a mutace $7 D009154
- 650 _2
- $a nádorové proteiny $x genetika $x metabolismus $7 D009363
- 650 _2
- $a jaderné proteiny $x genetika $x metabolismus $7 D009687
- 650 _2
- $a fosfoproteiny $x genetika $x metabolismus $7 D010750
- 650 _2
- $a proteiny vázající RNA $x genetika $x metabolismus $7 D016601
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Holoubek, Aleš $u Institute of Hematology and Blood Transfusion, U Nemocnice 1, 128 20 Prague 2, Czech Republic.
- 700 1_
- $a Otevřelová, Petra $u Institute of Hematology and Blood Transfusion, U Nemocnice 1, 128 20 Prague 2, Czech Republic.
- 700 1_
- $a Kuželová, Kateřina $u Institute of Hematology and Blood Transfusion, U Nemocnice 1, 128 20 Prague 2, Czech Republic.
- 700 1_
- $a Brodská, Barbora $u Institute of Hematology and Blood Transfusion, U Nemocnice 1, 128 20 Prague 2, Czech Republic. Electronic address: brodska@uhkt.cz.
- 773 0_
- $w MED00006475 $t The international journal of biochemistry & cell biology $x 1878-5875 $g Roč. 103, č. - (2018), s. 65-73
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30130654 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190813 $b ABA008
- 991 __
- $a 20190816131851 $b ABA008
- 999 __
- $a ok $b bmc $g 1433408 $s 1066719
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 103 $c - $d 65-73 $e 20180818 $i 1878-5875 $m International journal of biochemistry and cell biology $n Int J Biochem Cell Biol $x MED00006475
- GRA __
- $a NV16-30268A $p MZ0
- LZP __
- $a Pubmed-20190813